Scancell (LON:SCLP) Shares Pass Below Two Hundred Day Moving Average – Here’s What Happened

Scancell Holdings plc (LON:SCLP)’s stock price passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 11.40 ($0.15) and traded as low as GBX 7.85 ($0.10). Scancell shares last traded at GBX 7.97 ($0.10), with a volume of 252,161 shares.

Scancell Price Performance

The company has a market capitalization of £82.55 million, a PE ratio of -12.22 and a beta of 0.35. The firm has a fifty day simple moving average of GBX 8.74 and a 200 day simple moving average of GBX 11.40. The company has a debt-to-equity ratio of -566.79, a quick ratio of 13.01 and a current ratio of 3.42.

Scancell (LON:SCLP) last released its quarterly earnings data on Thursday, January 30th. The company reported GBX (1.35) (($0.02)) earnings per share for the quarter. Equities analysts anticipate that Scancell Holdings plc will post -2.5361112 EPS for the current year.

About Scancell

Scancell (LSE:SCLP) is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers.

Scancell has developed a pipeline of ‘off-the-shelf’ vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs.